Illumina withheld terms of the deal in a statement released this morning. Californian genetic analysis company Illumina has bought technology start-up Edico Genome for $100m. The deal is the latest in a series of acquisitions by the San Francisco-based company, which specialises in sequencing DNA and other biological data. system tackles a bottleneck in DNA reading technology and has cut the time for genome mapping from 20 hours to 20 minutes. Last year the company adapted its technology for use with cloud platforms, including Amazon Web Services. Illumina said the acquisition would help make data acquisition and analysis a standardised process, and that Edico’s technology complemented its own systems. It also supported a call for the scientific community to adopt standards for the use of genomics in health.
Californian genetic analysis company Illumina has bought technology start-up Edico Genome for $100m. The deal is the latest in a series of acquisitions by the San Francisco-based company, which specialises in sequencing DNA and other biological data. system tackles a bottleneck in DNA reading technology and has cut the time for genome mapping from 20 hours to 20 minutes. Last year the company adapted its technology for use with cloud platforms, including Amazon Web Services. Illumina said the acquisition would help make data acquisition and analysis a standardised process, and that Edico’s technology complemented its own systems. It also supported a call for the scientific community to adopt standards for the use of genomics in health.